...
首页> 外文期刊>Journal of applied clinical medical physics / >Secondary monitor unit calculations for VMAT using parallelized Monte Carlo simulations
【24h】

Secondary monitor unit calculations for VMAT using parallelized Monte Carlo simulations

机译:使用并行化的蒙特卡洛模拟对VMAT进行辅助监视的计算

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We have developed a fast and accurate in‐house Monte Carlo (MC) secondary monitor unit (MU) check method, based on the EGSnrc system, for independent verification of volumetric modulated arc therapy (VMAT) treatment planning system dose calculations, in accordance with TG‐114 recommendations. For a VMAT treatment plan created for a Varian Trilogy linac, DICOM information was exported from Eclipse. An open‐source platform was used to generate input files for dose calculations using the EGSnrc framework. The full VMAT plan simulation employed 10sup7/sup histories, and was parallelized to run on a computer cluster. The resulting 3d dose matrices were converted to the DICOM format using CERR and imported into Eclipse. The method was evaluated using 35 clinical VMAT plans of various treatment sites. For each plan, the doses calculated with the MC approach at four three‐dimensional reference points were compared to the corresponding Eclipse calculations, as well as calculations performed using the clinical software package, MUCheck. Each MC arc simulation of 10sup7/sup particles required 13–25?min of total time, including processing and calculation. The average discrepancies in calculated dose values between the MC method and Eclipse were 2.03% (compared to 3.43% for MUCheck) for prostate cases, 2.45% (3.22% for MUCheck) for head and neck cases, 1.7% (5.51% for MUCheck) for brain cases, and 2.84% (5.64% for MUCheck) for miscellaneous cases. Of 276 comparisons, 201 showed greater agreement between the treatment planning system and MC vs MUCheck. The largest discrepancies between MC and MUCheck were found in regions of high dose gradients and heterogeneous densities. By parallelizing the calculations, point‐dose accuracies of 2‐7%, sufficient for clinical secondary checks, can be achieved in a reasonable amount of time. As computer clusters and/or cloud computing become more widespread, this method will be useful in most clinical setups.
机译:我们已经开发了一种基于EGSnrc系统的快速,准确的内部蒙特卡洛(MC)二级监视单元(MU)检查方法,用于根据验证的容积调制电弧疗法(VMAT)治疗计划系统剂量计算的独立验证TG‐114建议。对于为Varian Trilogy直线加速器创建的VMAT治疗计划,从Eclipse导出了DICOM信息。使用开源平台生成使用EGSnrc框架进行剂量计算的输入文件。完整的VMAT计划仿真使用10 7 历史记录,并并行运行在计算机集群上。使用CERR将所得的3d剂量矩阵转换为DICOM格式,然后导入Eclipse。使用不同治疗部位的35个临床VMAT计划对方法进行了评估。对于每个计划,将使用MC方法在四个三维参考点处计算出的剂量与相应的Eclipse计算以及使用临床软件包MUCheck进行的计算进行比较。每个10 7 粒子的MC电弧模拟都需要13-25分钟的总时间,包括处理和计算。 MC方法和Eclipse之间的计算剂量值的平均差异为:前列腺病例为2.03%(MUCheck为3.43%),头颈部病例为2.45%(MUCheck为3.22%),1.7%(MUCheck为5.51%)对于脑部病例,为2.84%(对于MUCheck,为5.64%)。在276项比较中,有201项显示治疗计划系统与MC vs MUCheck之间的一致性更高。 MC和MUCheck之间的最大差异是在高剂量梯度和异质密度区域中发现的。通过并行计算,可以在合理的时间内获得2–7%的点剂量准确度,足以进行临床二次检查。随着计算机集群和/或云计算的普及,此方法将在大多数临床设置中有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号